Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 23586950)

1.

Addressing endotoxin issues in bioengineered heparin.

Suwan J, Torelli A, Onishi A, Dordick JS, Linhardt RJ.

Biotechnol Appl Biochem. 2012 Nov-Dec;59(6):420-8. doi: 10.1002/bab.1042. Epub 2012 Oct 18.

PMID:
23586950
2.

Optimization of bioprocess conditions improves production of a CHO cell-derived, bioengineered heparin.

Baik JY, Dahodwala H, Oduah E, Talman L, Gemmill TR, Gasimli L, Datta P, Yang B, Li G, Zhang F, Li L, Linhardt RJ, Campbell AM, Gorfien SF, Sharfstein ST.

Biotechnol J. 2015 Jun 3. doi: 10.1002/biot.201400665. [Epub ahead of print]

PMID:
26037948
3.

Pseudohyperphosphatemia due to contamination with heparin: A case for caution.

Senthilkumaran S, Menezes RG, Jayaraman S, Thirumalaikolundusubramanian P.

Indian J Nephrol. 2014 Nov;24(6):409-10. doi: 10.4103/0971-4065.133040. No abstract available.

4.

Bioengineered heparin: is there a future for this form of the successful therapeutic?

Lord MS, Whitelock JM.

Bioengineered. 2014 Jul-Aug;5(4):222-6. doi: 10.4161/bioe.29388. Epub 2014 Jun 5.

5.

Challenges facing sterilization and depyrogenation of nanoparticles: effects on structural stability and biomedical applications.

Vetten MA, Yah CS, Singh T, Gulumian M.

Nanomedicine. 2014 Oct;10(7):1391-9. doi: 10.1016/j.nano.2014.03.017. Epub 2014 Apr 4. Review.

PMID:
24709329
6.

Allantoin as a solid phase adsorbent for removing endotoxins.

Vagenende V, Ching TJ, Chua RJ, Gagnon P.

J Chromatogr A. 2013 Oct 4;1310:15-20. doi: 10.1016/j.chroma.2013.08.043. Epub 2013 Aug 19.

PMID:
24001944
7.

Polymyxin-B endotoxin removal device: making the point on mechanisms of action, clinical effectiveness and possible future applications: review.

Ruberto F, Ianni S, Babetto C, Magnanimi E, Ferretti G, Novelli G, Pugliese F.

Infect Disord Drug Targets. 2013 Apr;13(2):128-32. Review.

PMID:
23919356
8.

[Study on preparation and property of a new adsorbent for endotoxin removal in blood purification].

Wang F, Wang X, Xiong Y, Xu P, Jin X, Tang J, Mao J.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2013 Jun;30(3):635-40. Chinese.

PMID:
23865333
9.

Immobilized enzymes to convert N-sulfo, N-acetyl heparosan to a critical intermediate in the production of bioengineered heparin.

Xiong J, Bhaskar U, Li G, Fu L, Li L, Zhang F, Dordick JS, Linhardt RJ.

J Biotechnol. 2013 Sep 10;167(3):241-7. doi: 10.1016/j.jbiotec.2013.06.018. Epub 2013 Jul 5.

10.
11.

Endotoxin removal and prevention for pre-clinical biologics production.

Serdakowski London A, Kerins B, Tschantz WR, Eisfeld J, Mackay K.

Biotechnol J. 2012 Dec;7(12):1509-16. doi: 10.1002/biot.201200220. Epub 2012 Nov 9. Erratum in: Biotechnol J. 2013 Aug;8(8):957. Eisfeld, Jochen [added].

PMID:
23081824
12.

Adsorption of various antimicrobial agents to endotoxin removal polymyxin-B immobilized fiber (Toraymyxin®). Part 2: Adsorption of two drugs to Toraymyxin PMX-20R cartridges.

Shimokawa K, Takakuwa R, Wada Y, Yamazaki N, Ishii F.

Colloids Surf B Biointerfaces. 2013 Jan 1;101:350-2. doi: 10.1016/j.colsurfb.2012.06.032. Epub 2012 Jul 5.

PMID:
23010040
13.

Methods for chromatographic removal of endotoxin.

Lowe AJ, Bardliving CL, Batt CA.

Methods Mol Biol. 2012;899:265-75. doi: 10.1007/978-1-61779-921-1_17.

PMID:
22735959
14.

Engineering of routes to heparin and related polysaccharides.

Bhaskar U, Sterner E, Hickey AM, Onishi A, Zhang F, Dordick JS, Linhardt RJ.

Appl Microbiol Biotechnol. 2012 Jan;93(1):1-16. doi: 10.1007/s00253-011-3641-4. Epub 2011 Nov 3. Review.

15.

Adsorption of various antimicrobial agents to endotoxin removal polymyxin-B immobilized fiber (Toraymyxin®).

Shimokawa K, Takakuwa R, Taya K, Wada Y, Yamazaki N, Murata M, Hirata K, Masuno T, Yokota H, Ishii F.

Colloids Surf B Biointerfaces. 2012 Feb 1;90:58-61. doi: 10.1016/j.colsurfb.2011.09.046. Epub 2011 Oct 5.

PMID:
22024401
16.

Competitive inhibition of heparinase by persulfonated glycosaminoglycans: a tool to detect heparin contamination.

Aich U, Shriver Z, Tharakaraman K, Raman R, Sasisekharan R.

Anal Chem. 2011 Oct 15;83(20):7815-22. doi: 10.1021/ac201498a. Epub 2011 Sep 19.

17.

Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock.

Mitaka C, Tomita M.

Shock. 2011 Oct;36(4):332-8. doi: 10.1097/SHK.0b013e318225f839. Review.

PMID:
21654557
18.

Escherichia coli K5 heparosan fermentation and improvement by genetic engineering.

Wang Z, Dordick JS, Linhardt RJ.

Bioeng Bugs. 2011 Jan-Feb;2(1):63-7. doi: 10.4161/bbug.2.1.14201.

19.

Assessing the removal potential of soil-aquifer treatment system (soil column) for endotoxin.

Guizani M, Kato H, Funamizu N.

J Environ Monit. 2011 Jun;13(6):1716-22. doi: 10.1039/c1em10071h. Epub 2011 May 13.

PMID:
21566853
20.

[Effect of affinity medium and solution conditions on endotoxin removal from protein solutions].

Xing H, Huang Y, Li Y, Luo J, Zhang L, Ma G, Su Z.

Sheng Wu Gong Cheng Xue Bao. 2010 Nov;26(11):1584-95. Chinese.

PMID:
21284220
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk